Genetic study in renal transplant patients

Not Applicable

Completed

• Conditions: Health Condition 1: null- Renal transplant

• Registration Number: CTRI/2018/04/013495
• Lead Sponsor: Seth GS Medical College and KEM Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-10-10
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Renal allograft recipients on tacrolimus therapy [for at least three months] attending transplant clinic

Willing to give written, informed consent

Exclusion Criteria

Subjects requiring tacrolimus dose adjustment of tacrolimus for reasons other than optimum C 0 levels. (eg BK Virus Cytomegalovirus Infection)

Patients requiring cessation of tacrolimus therapy due to primary graft non-function graft nephrectomy

ABO incompatible transplant

Patient with positive Donor Specific Antibodies with or without desensitization and panel reactive antibody > 50%

Patients >60 years with cognitive impairment (as assessed by a neurologist) will be excluded from the study

Patients [deemed by the investigator] to have data on records incomplete to fulfil the study objectives

Study & Design

• Study Type: Observational
• Study Design: Not specified